Hikma Pharmaceutical agrees to buy Custopharm for $375 million
Hikma Pharmaceutical , Custopharm , acquire, Waster Street Healthcare Partners, LONDON, UK: Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company and one of the largest suppliers of generic injectable medicines in the US, has agreed to acquire Custopharm Inc. from Water Street…